share_log

藥明康德:翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

HKEX ·  Sep 24 05:56

Summary by Moomoo AI

無錫藥明康德新藥開發股份有限公司(药明康德)於2024年9月24日提交了翌日披露報表,披露公司在上海證券交易所進行的股份回購活動。根據報表,药明康德在2024年9月11日至9月24日期間,通過多次交易回購了總計11,204,595股A股股份,佔已發行股份的約0.44%。回購的股份尚未註銷,並將擬註銷。公司確認,這些股份回購活動已獲董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。股份回購後,公司的已發行股份總數維持在2,524,851,053股。
無錫藥明康德新藥開發股份有限公司(药明康德)於2024年9月24日提交了翌日披露報表,披露公司在上海證券交易所進行的股份回購活動。根據報表,药明康德在2024年9月11日至9月24日期間,通過多次交易回購了總計11,204,595股A股股份,佔已發行股份的約0.44%。回購的股份尚未註銷,並將擬註銷。公司確認,這些股份回購活動已獲董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。股份回購後,公司的已發行股份總數維持在2,524,851,053股。
Wuxi Apptec (药明康德) submitted the disclosure report the next day on September 24, 2024, disclosing the share repurchase activities conducted by the company on the Shanghai Stock Exchange. According to the report, Wuxi Apptec repurchased a total of 11,204,595 A-shares between September 11 and September 24, 2024, accounting for approximately 0.44% of the issued shares. The repurchased shares have not been canceled yet but are intended to be cancelled. The company confirmed that these share repurchase activities have been formally authorized and approved by the board of directors, and comply with all applicable listing rules, laws, and other regulatory requirements. After the share repurchase, the total number of issued shares of the company remains at 2,524,851,053 shares.
Wuxi Apptec (药明康德) submitted the disclosure report the next day on September 24, 2024, disclosing the share repurchase activities conducted by the company on the Shanghai Stock Exchange. According to the report, Wuxi Apptec repurchased a total of 11,204,595 A-shares between September 11 and September 24, 2024, accounting for approximately 0.44% of the issued shares. The repurchased shares have not been canceled yet but are intended to be cancelled. The company confirmed that these share repurchase activities have been formally authorized and approved by the board of directors, and comply with all applicable listing rules, laws, and other regulatory requirements. After the share repurchase, the total number of issued shares of the company remains at 2,524,851,053 shares.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more